All Relations between Schizophrenia and Aripiprazole

Publication Sentence Publish Date Extraction Date Species
Jong-Il Park, Tong Zhao, Guang-Biao Huang, Zhi-Yan Sui, Chun-Rong Li, Eui-Hyeog Han, Young-Chul Chun. Effects of Aripiprazole and Haloperidol on Fos-like Immunoreactivity in the Prefrontal Cortex and Amygdala. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 9. issue 1. 2013-02-25. PMID:23431025. aripiprazole, a dopamine system stabilizer, shows efficacy against both negative symptoms and positive symptoms in patients with schizophrenia. 2013-02-25 2023-08-12 rat
Hiroshi Ito, Harumasa Takano, Ryosuke Arakawa, Hidehiko Takahashi, Fumitoshi Kodaka, Keisuke Takahata, Tsuyoshi Nogami, Masayuki Suzuki, Tetsuya Suhar. Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA. PloS one. vol 7. issue 9. 2013-02-20. PMID:23029533. the therapeutic effects of aripiprazole in schizophrenia might be related to such stabilizing effects on dopaminergic neurotransmission responsivity. 2013-02-20 2023-08-12 human
Emilio Russo, Rita Citraro, Alessandro Davoli, Luca Gallelli, Eugenio Donato Di Paola, Giovambattista De Sarr. Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology. vol 64. 2013-02-11. PMID:22766393. aripiprazole (apz) is regarded as a first-line atypical antipsychotic used for the treatment of first and multiple episodes of schizophrenia to improve positive- and negative-symptoms. 2013-02-11 2023-08-12 rat
P Ratajczak, K Kus, Z Jarmuszkiewicz, A Woźniak, E Nowakowsk. The effect of ethyl alcohol on the function of spatial memory in rats. Arzneimittel-Forschung. vol 62. issue 12. 2013-02-11. PMID:23115060. alcoholism is a mental disease in the course of which depression, anxiety, and cognitive function deficits may appear, and these symptoms can be aggravated by comorbid schizophrenia.the aim of this study was to find whether spatial memory (morris water maze) function impairment is found in prenatally stressed rats (psg) (prenatal stress paradigm - animal model of schizophrenia) and whether aripiprazole ari and olanzapine ola modify these functions. 2013-02-11 2023-08-12 rat
Itaru Miura, Satoshi Takeuchi, Akihiko Katsumi, Keiko Kanno, Kenya Watanabe, Hirobumi Mashiko, Shin-Ichi Niw. Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia. Human psychopharmacology. vol 27. issue 5. 2013-02-05. PMID:22927115. effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia. 2013-02-05 2023-08-12 Not clear
Itaru Miura, Satoshi Takeuchi, Akihiko Katsumi, Keiko Kanno, Kenya Watanabe, Hirobumi Mashiko, Shin-Ichi Niw. Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia. Human psychopharmacology. vol 27. issue 5. 2013-02-05. PMID:22927115. we investigated the effects of risperidone on plasma levels of homovanillic acid (hva) and 3-methoxy-4hydroxyphenylglycol after unsuccessful aripiprazole treatment in acute schizophrenia. 2013-02-05 2023-08-12 Not clear
Hoda Moteshafi, Emmanuel Sti. Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. Expert opinion on drug safety. vol 11. issue 5. 2013-01-21. PMID:22913713. comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. 2013-01-21 2023-08-12 Not clear
Norio Yasui-Furukori, Ayako Kaneda, Norio Sugawara, Tetsu Tomita, Sunao Kanek. Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients. Journal of psychopharmacology (Oxford, England). vol 26. issue 6. 2013-01-15. PMID:21616975. effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients. 2013-01-15 2023-08-12 Not clear
Norio Yasui-Furukori, Ayako Kaneda, Norio Sugawara, Tetsu Tomita, Sunao Kanek. Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients. Journal of psychopharmacology (Oxford, England). vol 26. issue 6. 2013-01-15. PMID:21616975. aripiprazole, which is a partial dopamine d2 receptor agonist, may have an impact on cognitive dysfunction in patients with schizophrenia. 2013-01-15 2023-08-12 Not clear
Norio Yasui-Furukori, Ayako Kaneda, Norio Sugawara, Tetsu Tomita, Sunao Kanek. Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients. Journal of psychopharmacology (Oxford, England). vol 26. issue 6. 2013-01-15. PMID:21616975. this study administered aripiprazole or placebo to 36 outpatients with schizophrenia also receiving risperidone or olanzapine for 12 weeks in a double-blind, randomized, placebo-controlled study. 2013-01-15 2023-08-12 Not clear
Yuejin Chen, William V Bobo, Kara Watts, Karuna Jayathilake, Tinlai Tang, Herbert Y Meltze. Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study. Journal of psychopharmacology (Oxford, England). vol 26. issue 9. 2013-01-11. PMID:22234928. we studied the effects of switching antipsychotic drug-treated patients with schizophrenia or bipolar disorder who evidenced adverse metabolic side effects as indicated by a triglyceride/high-density lipoprotein ratio (tg/hdl) ≥ 3.5 to aripiprazole (arip; 5-30 mg/day, n = 24) or ziprasidone (zip; 40-160 mg/day, n = 28). 2013-01-11 2023-08-12 Not clear
Leslie Citrome, Zhenchao Guo, Iftekhar Kalsekar, Robert A Forbes, Tony Hebde. Trends in combination antipsychotic use among persons with commercial insurance: a data snapshot. Innovations in clinical neuroscience. vol 9. issue 3. 2013-01-10. PMID:22567605. although all three diagnostic groups were associated with varying amounts of combination antipsychotic use that included aripiprazole, olanzapine, quetiapine, risperidone and ziprasidone, persons with schizophrenia exhibited the highest rates. 2013-01-10 2023-08-12 Not clear
Mark Olfson, Tobias Gerhard, Cecilia Huang, Jeffrey A Lieberman, William V Bobo, Stephen Crysta. Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia. Schizophrenia bulletin. vol 38. issue 4. 2012-12-27. PMID:21307041. a 45-state medicaid claims file (2001-2005) was analyzed focusing on outpatients, aged 6-17 years, diagnosed with schizophrenia or a related disorder prior to starting a new episode of antipsychotic monotherapy with risperidone (n = 805), olanzapine (n = 382), quetiapine (n = 260), aripiprazole (n = 173), or ziprasidone (n = 125). 2012-12-27 2023-08-12 Not clear
Christopher S Wisniewski, Sophie Rober. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia. The Annals of pharmacotherapy. vol 46. issue 7-8. 2012-12-26. PMID:22811346. strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia. 2012-12-26 2023-08-12 Not clear
Christopher S Wisniewski, Sophie Rober. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia. The Annals of pharmacotherapy. vol 46. issue 7-8. 2012-12-26. PMID:22811346. to determine the optimal approach for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia and to describe these strategies. 2012-12-26 2023-08-12 Not clear
Jyotik T Bhachec. Aripiprazole-induced oculogyric crisis (acute dystonia). Journal of pharmacology & pharmacotherapeutics. vol 3. issue 3. 2012-11-07. PMID:23129969. aripiprazole is the third generation atypical antipsychotic and a dopamine serotonin system stabilizer (dss) effective against positive and negative symptoms of schizophrenia. 2012-11-07 2023-08-12 Not clear
Jyotik T Bhachec. Aripiprazole-induced oculogyric crisis (acute dystonia). Journal of pharmacology & pharmacotherapeutics. vol 3. issue 3. 2012-11-07. PMID:23129969. a thorough workup and vigilance is required prior to initiation of aripiprazole in the case of schizophrenia. 2012-11-07 2023-08-12 Not clear
Tsuyoshi Sasaki, Tasuku Hashimoto, Tomihisa Niitsu, Nobuhisa Kanahara, Masaomi Iy. Treatment of refractory catatonic schizophrenia with low dose aripiprazole. Annals of general psychiatry. vol 11. issue 1. 2012-10-18. PMID:22553911. treatment of refractory catatonic schizophrenia with low dose aripiprazole. 2012-10-18 2023-08-12 Not clear
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Kenji Hayashi, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Jun Nakamur. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients. Journal of psychiatric research. vol 46. issue 6. 2012-10-17. PMID:22464338. the cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients. 2012-10-17 2023-08-12 Not clear
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Kenji Hayashi, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Jun Nakamur. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients. Journal of psychiatric research. vol 46. issue 6. 2012-10-17. PMID:22464338. we investigated the effects of the atypical antipsychotics risperidone, olanzapine, and aripiprazole on the cognitive functions of japanese patients with schizophrenia with respect to dosage amounts and dosing schedules. 2012-10-17 2023-08-12 Not clear